Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartphone app help quiet suicidal thoughts?

NCT ID NCT07440004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This study tests whether a 4-week mindfulness app called the Healthy Minds Program is practical and well-liked by adults who have had suicidal thoughts in the past month. Fifty participants will use the app and complete questionnaires. The goal is to see if the app is easy to use and shows early signs of helping.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Healthy Minds Program (HMP) smartphone app
What this could lead to
If it works, this could point toward a simple, accessible digital tool to help ease suicidal thoughts.
What could go wrong
This is a very early, small feasibility study (50 people) with no control group. The app may not reduce suicidal thoughts, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

30 people

The number who actually took part.

Started

Apr 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 18 or older * past month history of active suicidal ideation * English speaking * primary owner of smartphone * has regular access to the internet * able to validate their identity with a valid form of legal ID (via driver's license, student ID, state-issued ID, etc.) * able to understand the nature of the study, provide informed consent, and complete study procedures Exclusion Criteria: * unable to understand the study procedures * not fluent in English * being unable to verify their identity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Wisconsin - Madison

    Madison, Wisconsin, 53703, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.